$0.615
-0.000 (-0.03%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BBLG Prediction & Forecast by Similar Chart Analysis
Alphio's BBLG stock price prediction model matches the current Bone Biologics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.62 (+0.50%). The 1-week path is $0.61 (-1.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Bone Biologics Corp Stock?
Bone Biologics Corp (BBLG) is not a good buy right now due to its poor financial performance and negative market trends. The stock has a current price of $0.61, a year-to-date change of -60.06%, and a 1-year change of -70.99%. Additionally, the RSI is at 28.146, indicating that the stock is oversold, but this may not be a strong enough signal to warrant a buy given the overall downward trend. The main risk is the company's ongoing losses, with a net income of -4153506 USD in Q3 2024 and a forward P/E ratio of 0, suggesting no earnings growth is expected in the near term.
BBLG stock price ended at $0.62 on Friday, after losing -0.03%
Bone Biologics Corp (BBLG) last closed at $0.615, losing -0.03%. These facts feed the 1-day and 1-week BBLG price prediction above.
Forecast Drivers
Bone Biologics Corp (BBLG) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BBLG, ranked by similarity.
Seasonality analysis for BBLG
Historically the probability of a positive August return for BBLG is 0.00%. January offers the highest probability of a positive month at 63.93%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BBLG
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.62 | $2.75 | $2.99 | +347.63% |
| Sep 2026 | $2.78 | $3.10 | $3.58 | +403.31% |
| Oct 2026 | $2.74 | $3.22 | $3.35 | +422.87% |
| Nov 2026 | $2.09 | $2.55 | $2.78 | +315.05% |
| Dec 2026 | $3.18 | $3.45 | $3.64 | +461.54% |
In 2026, Bone Biologics Corp (BBLG) is projected to range from $2.09 to $3.64.
Bone Biologics Corp 2026 monthly forecast
In Aug 2026, Bone Biologics Corp is projected to average $2.75, with a low of $2.62 and high of $2.99.
In Sep 2026, Bone Biologics Corp is projected to average $3.10, with a low of $2.78 and high of $3.58.
In Oct 2026, Bone Biologics Corp is projected to average $3.22, with a low of $2.74 and high of $3.35.
In Nov 2026, Bone Biologics Corp is projected to average $2.55, with a low of $2.09 and high of $2.78.
In Dec 2026, Bone Biologics Corp is projected to average $3.45, with a low of $3.18 and high of $3.64.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.